Assembly Biosciences (ASMB) Non-Current Assets (2010 - 2026)

Assembly Biosciences' Non-Current Assets history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• On a quarterly basis, Non-Current Assets fell 17.05% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $12.4 million, a 7.23% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, down 17.03% from the prior year.
• Non-Current Assets retreated to $2.9 million in Q1 2026 per ASMB's latest filing, from $3.0 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $32.0 million in Q1 2022 and bottomed at $2.0 million in Q3 2023.
• The 5-year median for Non-Current Assets is $3.2 million (2025), against an average of $5.9 million.
• Across the five-year window, Non-Current Assets tumbled 89.45% in 2023 and jumped 55.44% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $4.8 million in 2022, then slumped by 37.1% to $3.0 million in 2023, then increased by 20.72% to $3.7 million in 2024, then retreated by 17.03% to $3.0 million in 2025, then fell by 4.8% to $2.9 million in 2026.
• Per Business Quant, the three latest ASMB Non-Current Assets figures stand at $2.9 million (Q1 2026), $3.0 million (Q4 2025), and $3.2 million (Q3 2025).